Sai Life Sciences Limited
SAILIFE
Rang in aandelen
#4711
Sai Life Sciences Limited operates as a contract research, development, and... Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Aandeelprijs
$14.78
Marktkapitalisatie
$3.14B
Verandering (1 dag)
-4.18%
Verandering (1 jaar)
47.89%
Land
IN
Handel Sai Life Sciences Limited (SAILIFE)
Categorie
Healthcare
P/B-ratio voor Sai Life Sciences Limited (SAILIFE)
P/B-ratio op October 2026 TTM: 11.90
Volgens de meest recente financiële rapporten en aandelenkoers van Sai Life Sciences Limited is de huidige P/B-ratio (TTM) 11.90. Eind 2025 had het bedrijf een P/B-ratio van 6.85.
P/B-ratiohistoriek voor Sai Life Sciences Limited van 2025 tot 2026
P/B-ratio aan het einde van elk jaar
| Jaar | P/B-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 11.90 | 73.78% |
| 2025 | 6.85 | 0.00% |
P/B-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/B-ratio | Verschil in P/B-ratio | Land |
|---|---|---|---|
| 4.5801 | -61.53% |
US
|
|
| 3.0725 | -74.19% |
US
|
|
| 31.4903 | 164.53% |
US
|
|
| 4.9326 | -58.56% |
CN
|
|
| 6.8081 | -42.81% |
US
|
